|
|
Volumn 9, Issue 7, 2000, Pages 1625-1634
|
|
D-sotalol: Death by the SWORD or deserving of further consideration for clinical use?
|
|
Author keywords
Class III anti arrhythmic agents; Clinical trials; D sotalol
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
POTASSIUM;
POTASSIUM CHANNEL;
SOTALOL;
ADRENERGIC SYSTEM;
ANTIARRHYTHMIC ACTIVITY;
DOG;
DRUG BIOAVAILABILITY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
HEART MUSCLE POTENTIAL;
HEART SUPRAVENTRICULAR ARRHYTHMIA;
HEART VENTRICLE ARRHYTHMIA;
HUMAN;
NONHUMAN;
REVIEW;
|
|
EID: 0033937741
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.7.1625 Document Type: Review |
|
Times cited : (9)
|
|
References (48)
|
